Effective treatment of human lung cancer by targeting tissue factor with a factor vii-targeted photodynamic therapy

Current Cancer Drug Targets

Volumn 11, Issue 9, 2011, Pages 1069-1081

  Cheng, J ^a   Xu, J ^a   Duanmu, J ^a   Zhou, H ^a   Booth, C J ^a   Hu, Z ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dual neovascular and cancer cell targeting photodynamic therapy; Factor VII; Ligand targeted photodynamic therapy; Lung cancer; Tissue factor

Indexed keywords

BLOOD CLOTTING FACTOR 7; THROMBOPLASTIN;

APOPTOSIS; ARTICLE; CANCER CELL; CELL STRAIN A549; CELL STRAIN H460; DRUG EFFICACY; DRUG TARGETING; ENDOTHELIUM CELL; HUMAN; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; LUNG NON SMALL CELL CANCER; NONHUMAN; PHOTODYNAMIC THERAPY; TUMOR XENOGRAFT;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; ENDOTHELIUM, VASCULAR; FACTOR VII; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, NUDE; NECROSIS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RECOMBINANT PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 81155126190     PISSN: 15680096     EISSN: 18735576     Source Type: Journal    
DOI: 10.2174/156800911798073023     Document Type: Article

References (82)

1. Decker, R. H.; Tanoue, L. T.; Colasanto, J. M.; Detterbeck, F. C.; Wilson, L. D. Evaluation and definitive management of medically inoperable early stage non-small-cell lung cancer. Part 2: newer treatment modalities. Oncology 2006, 20, 899-905.
2. Collins, A. S.; Garner, M. Caring for lung cancer patients receiving photodynamic therapy. Crit. Care Nurse 2007, 27, 53-60.
3. Kennedy, B.; Gargoum, F.; Bystricky, B; Curran, D. R.; O'Connor, T. M. Novel agents in the management of lung cancer. Curr. Med.Chem. 2010, 17, 4291-4325.
4. Webb, J. D; Simon, M. C. Novel insights into the molecular origins and treatment of lung cancer. Cell Cycle 2010, 9, 4098-4105.
5. Gomer, C. J. Photodynamic therapy in the treatment of malignancies. Semin. Hematol. 1989, 26, 27-34.
6. Oleinick, N. L.; Evans, H. H. The photobiology of photodynamic therapy: cellular targets and mechanisms. Radiat. Res. 1998, 150, S146-S156.
7. Castano, A. P.; Mroz, P.; Hamblin, M. R. Photodynamic therapy and anti-tumour immunity. Nat. Rev. Cancer 2006, 6, 535-545.
8. Kato, H.; Kawate, N.; Kinoshita, K.; Yamamoto, H.; Furukawa, K.; Hayata, Y. Photodynamic therapy of early-stage lung cancer. Ciba Found. Symp. 1989, 146, 183-94; discussion 195-197.
9. Banerjee, A.; George, J. Bronchoscopic photodynamic diagnosis and therapy for lung cancer. Curr. Opin. Pulm. Med. 2000, 6, 378-383.
10. Ost, D. Photodynamic therapy in lung cancer. A review. Methods Mol. Med. 2003, 75, 507-526.
11. Maziak, D. E.; Markman, B. R.; MacKay, J. A.; Evans, W. K. Photodynamic therapy in nonsmall cell lung cancer: a systematic review. Ann. Thorac. Surg. 2004, 77, 1484-1491.
12. Usuda, J.; Kato, H.; Okunaka, T.; Furukawa, K.; Tsutsui, H.; Yamada, K.; Suga, Y.; Honda, H.; Nagatsuka, Y.; Ohira, T.; Tsuboi, M.; Hirano, T. Photodynamic therapy (PDT) for lung cancers. J. Thorac. Oncol. 2006, 1, 489-493.
13. Moghissi, K.; Dixon, K.; Thorpe, J. A.; Stringer, M.; Oxtoby, C. Photodynamic therapy (PDT) in early central lung cancer: a treatment option for patients ineligible for surgical resection. Thorax 2007, 62, 391-395.
14. Juarranz, A.; Jaen, P.; Sanz-Rodriguez, F.; Cuevas, J.; Gonzalez, S. Photodynamic therapy of cancer. Basic principles and applications. Clin. Transl. Oncol. 2008, 10, 148-154.
15. Minnich, D. J.; Bryant, A. S.; Dooley, A.; Cerfolio, R. J. Photodynamic laser therapy for lesions in the airway. Ann. Thorac. Surg. 2010, 89, 1744-1748.
16. Usuda, J.; Ichinose, S.; Ishizumi, T.; Hayashi, H.; Ohtani, K.; Maehara, S.; Ono, S.; Kajiwara, N.; Uchida, O.; Tsutsui, H.; Ohira, T.; Kato, H.; Ikeda, N. Management of multiple primary lung cancer in patients with centrally located early cancer lesions. J. Thorac. Oncol. 2010, 5, 62-68.
17. Weinberg, B. D.; Allison, R. R.; Sibata, C.; Parent, T.; Downie, G. Results of combined photodynamic therapy (PDT) and high dose rate brachytherapy (HDR) in treatment of obstructive endobronchial non-small cell lung cancer (NSCLC). Photodiagnosis Photodyn. Ther. 2010, 7, 50-58.
18. Issa, M. C.; Manela-Azulay, M. Photodynamic therapy: a review of the literature and image documentation. An. Bras. Dermatol. 2010, 85, 501-511.
19. Nowis, D.; Makowski, M.; Stoklosa, T.; Legat, M.; Issat, T.; Golab, J. Direct tumor damage mechanisms of photodynamic therapy. Acta Biochim. Pol. 2005, 52, 339-352.
20. Filip, A. G.; Clichici, S.; Daicoviciu, D.; Olteanu, D.; Muresan, A.; Dreve, S. Photodynamic therapy--indications and limits in malignant tumors treatment. Rom. J. Intern. Med. 2008, 46, 285-293.
21. Taber, S. W.; Fingar, V. H.; Wieman, T. J. Photodynamic therapy for palliation of chest wall recurrence in patients with breast cancer. J. Surg. Oncol. 1998, 68, 209-214.
22. Teicher, B. A. Antibody-drug conjugate targets. Curr. Cancer Drug Targets 2009, 9, 982-1004.
23. Chari, R. V. Targeted cancer therapy: conferring specificity to cytotoxic drugs. Acc. Chem. Res. 2008, 41, 98-107.
24. Trail, P. A.; King, H. D.; Dubowchik, G. M. Monoclonal antibody drug immunoconjugates for targeted treatment of cancer. Cancer Immunol. Immunother. 2003, 52, 328-337.
25. Sharman, W. M.; van Lier, J. E.; Allen, C. M. Targeted photodynamic therapy via receptor mediated delivery systems. Adv. Drug Deliv. Rev. 2004, 56, 53-76.
26. Mayo, G. L.; Melendez, R. F.; Kumar, N.; McKinnon, S. J.; Glickman, R. D. Antibody-targeted photodynamic therapy. Am. J. Ophthalmol. 2003, 136, 1151-1152.
27. Bechet, D.; Tirand, L.; Faivre, B.; Plenat, F.; Bonnet, C.; Bastogne, T.; Frochot, C.; Guillemin, F.; Barberi-Heyob, M. Neuropilin-1 targeting photosensitization-induced early stages of thrombosis via tissue factor release. Pharm. Res. 2010, 27, 468-479.
28. Hu, Z.; Rao, B.; Chen, S.; Duanmu, J. Targeting tissue factor on tumour cells and angiogenic vascular endothelial cells by factor VII-targeted verteporfin photodynamic therapy for breast cancer in vitro and in vivo in mice. BMC Cancer 2010, 10, 235.
29. Duanmu, J.; Cheng, J.; Xu, J.; Booth, C. J.; Hu, Z. Effective treatment of chemoresistant breast cancer in vitro and in vivo by a factor VII-targeted photodynamic therapy. Br. J. Cancer 2011, 104, 1401-1409.
30. Hu, Z.; Rao, B.; Chen, S.; Duanmu, J. Selective and effective killing of angiogenic vascular endothelial cells and cancer cells by targeting tissue factor using a factor VII-targeted photodynamic therapy for breast cancer. Breast Cancer Res. Treat. 2011, 126, 589-600.
31. Hu, Z.; Sun, Y.; Garen, A. Targeting tumor vasculature endothelial cells and tumor cells for immunotherapy of human melanoma in a mouse xenograft model. Proc. Natl. Acad. Sci. U. S. A. 1999, 96, 8161-8166.
32. Hu, Z.; Garen, A. Intratumoral injection of adenoviral vectors encoding tumor-targeted immunoconjugates for cancer immunotherapy. Proc. Natl. Acad. Sci. U. S. A. 2000, 97, 9221-9225.
33. Hu, Z.; Garen, A. Targeting tissue factor on tumor vascular endothelial cells and tumor cells for immunotherapy in mouse models of prostatic cancer. Proc. Natl. Acad. Sci. U. S. A. 2001, 98, 12180-12185.
34. Hu, Z.; Li, J. Natural killer cells are crucial for the efficacy of Icon (factor VII/human IgG1 Fc) immunotherapy in human tongue cancer. BMC Immunol. 2010, 11, 49.
35. Lu, F.; Hu, Z.; Sinard, J.; Garen, A.; Adelman, R. A. Factor VII-verteporfin for targeted photodynamic therapy in a rat model of choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 2009, 50, 3890-3896.
36. Fisher, K. L.; Gorman, C. M.; Vehar, G. A.; O'Brien, D. P.; Lawn, R. M. Cloning and expression of human tissue factor cDNA. Thromb. Res. 1987, 48, 89-99.
37. Morrissey, J. H.; Fakhrai, H.; Edgington, T.S. Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade. Cell 1987, 50, 129-135.
38. Spicer, E. K.; Horton, R.; Bloem, L.; Bach, R.; Williams, K. R.; Guha, A.; Kraus, J.; Lin, T. C.; Nemerson, Y.; Konigsberg, W. H. Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA. Proc. Natl. Acad. Sci. U. S. A. 1987, 84, 5148-5152.
39. Konigsberg, W. H.; Nemerson, Y. Molecular cloning of the cDNA for human tissue factor. Cell 1988, 52, 639-640.
40. O'Hara, P. J.; Grant, F. J.; Haldeman, B. A.; Gray, C. L.; Insley, M. Y.; Hagen, F. S.; Murray, M. J. Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation. Proc. Natl. Acad. Sci. U. S. A. 1987, 84, 5158-5162.
41. Idusogie, E.; Rosen, E.; Geng, J. P.; Carmeliet, P.; Collen, D.; Castellino, F. J. Characterization of a cDNA encoding murine coagulation factor VII. Thromb. Haemost. 1996, 75, 481-487.
42. Idusogie, E.; Rosen, E. D.; Carmeliet, P.; Collen, D.; Castellino, F. J. Nucleotide structure and characterization of the murine blood coagulation factor VII gene. Thromb. Haemost. 1996, 76, 957-964.
43. Contrino, J.; Hair, G.; Kreutzer, D. L.; Rickles, F. R. In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nat. Med. 1996, 2, 209-215.
44. Takano, S.; Tsuboi, K.; Tomono, Y.; Mitsui, Y.; Nose, T. Tissue factor, osteopontin, alphavbeta3 integrin expression in microvasculature of gliomas associated with vascular endothelial growth factor expression. Br. J. Cancer 2000, 82, 1967-1973.
45. Tang, Y.; Borgstrom, P.; Maynard, J.; Koziol, J.; Hu, Z.; Garen, A.; Deisseroth, A. Mapping of angiogenic markers for targeting of vectors to tumor vascular endothelial cells. Cancer Gene Ther. 2007, 14, 346-353.
46. Bora, P. S.; Hu, Z.; Tezel, T. H.; Sohn, J. H.; Kang, S. G.; Cruz, J. M.; Bora, N. S.; Garen, A.; Kaplan, H. J. Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2003, 100, 2679-2684.
47. Tezel, T. H.; Bodek, E.; Sonmez, K.; Kaliappan, S.; Kaplan, H. J.; Hu, Z.; Garen, A. Targeting tissue factor for immunotherapy of choroidal neovascularization by intravitreal delivery of factor VII-Fc chimeric antibody. Ocul. Immunol. Inflamm. 2007, 15, 3-10.
48. Krikun, G.; Hu, Z.; Osteen, K.; Bruner-Tran, K. L.; Schatz, F.; Taylor, H. S.; Toti, P.; Arcuri, F.; Konigsberg, W.; Garen, A.; Booth, C. J.; Lockwood, C. J. The immunoconjugate icon targets aberrantly expressed endothelial tissue factor causing regression of endometriosis. Am. J. Pathol. 2010, 176, 1050-1056.
49. Drake, T. A.; Morrissey, J. H.; Edgington, T. S. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am. J. Pathol. 1989, 134, 1087-1097.
50. Flossel, C.; Luther, T.; Muller, M.; Albrecht, S.; Kasper, M. Immunohistochemical detection of tissue factor (TF) on paraffin sections of routinely fixed human tissue. Histochemistry 1994, 101, 449-453.
51. Capella, M. A.; Capella, L. S. A light in multidrug resistance: photodynamic treatment of multidrug-resistant tumors. J. Biomed. Sci. 2003, 10, 361-366.
52. Callander, N. S.; Varki, N.; Rao, L. V. Immunohistochemical identification of tissue factor in solid tumors. Cancer 1992, 70, 1194-1201.
53. Shoji, M.; Hancock, W. W.; Abe, K.; Micko, C.; Casper, K. A.; Baine, R. M.; Wilcox, J. N.; Danave, I.; Dillehay, D. L.; Matthews, E.; Contrino, J.; Morrissey, J. H.; Gordon, S.; Edgington, T. S.; Kudryk, B.; Kreutzer, D. L.; Rickles, F. R. Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Am. J. Pathol. 1998, 152, 399-411.
54. Fernandez, P. M.; Rickles, F. R. Tissue factor and angiogenesis in cancer. Curr. Opin. Hematol. 2002, 9, 401-406.
55. Forster, Y.; Meye, A.; Albrecht, S.; Schwenzer, B. Tissue factor and tumor: clinical and laboratory aspects. Clin. Chim. Acta 2006, 364, 12-21.
56. Milsom, C.; Anderson, G. M.; Weitz, J. I.; Rak, J. Elevated tissue factor procoagulant activity in CD133-positive cancer cells. J. Thromb. Haemost. 2007, 5, 2550-2552.
57. Cocco, E.; Hu, Z.; Richter, C. E.; Bellone, S.; Casagrande, F.; Bellone, M.; Todeschini, P.; Krikun, G.; Silasi, D. A.; Azodi, M.; Schwartz, P. E.; Rutherford, T. J.; Buza, N.; Pecorelli, S.; Lockwood, C. J.; Santin, A. D. hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor for immunotherapy of uterine serous papillary carcinoma. Br. J. Cancer 2010, 103, 812-819.
58. Keller, T.; Salge, U.; Konig, H.; Dodt, J.; Heiden, M.; Seitz, R. Tissue factor is the only activator of coagulation in cultured human lung cancer cells. Lung Cancer 2001, 31, 171-179.
59. Koomagi, R.; Volm, M. Tissue-factor expression in human non-small-cell lung carcinoma measured by immunohistochemistry: correlation between tissue factor and angiogenesis. Int. J. Cancer 1998, 79, 19-22.
60. Sawada, M.; Miyake, S.; Ohdama, S.; Matsubara, O.; Masuda, S.; Yakumaru, K.; Yoshizawa, Y. Expression of tissue factor in non-small-cell lung cancers and its relationship to metastasis. Br. J. Cancer 1999, 79, 472-477.
61. Wang, B.; Berger, M.; Masters, G.; Albone, E.; Yang, Q.; Sheedy, J.; Kirksey, Y.; Grimm, L.; Wang, B.; Singleton, J.; Soltis, D. Radiotherapy of human xenograft NSCLC tumors in nude mice with a 90Y-labeled anti-tissue factor antibody. Cancer Biother. Radiopharm. 2005, 20, 300-309.
62. Zacharski, L. R.; Schned, A. R.; Sorenson, G. D. Occurrence of fibrin and tissue factor antigen in human small cell carcinoma of the lung. Cancer Res. 1983, 43, 3963-3968.
63. Brower, M.; Carney, D. N.; Oie, H. K.; Gazdar, A. F.; Minna, J. D. Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium. Cancer Res. 1986, 46, 798-806.
64. Giard, D. J.; Aaronson, S. A.; Todaro, G. J.; Arnstein, P.; Kersey, J. H.; Dosik, H.; Parks, W. P. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst. 1973, 51, 1417-1423.
65. Yoneda, Y.; Arioka, T.; Imamoto-Sonobe, N.; Sugawa, H.; Shimonishi, Y.; Uchida, T. Synthetic peptides containing a region of SV 40 large T-antigen involved in nuclear localization direct the transport of proteins into the nucleus. Exp. Cell Res. 1987, 170, 439-452.
66. Dackiw, A. P.; McGilvray, I. D.; Woodside, M.; Nathens, A. B.; Marshall, J. C.; Rotstein, O. D. Prevention of endotoxin-induced mortality by antitissue factor immunization. Arch Surg. 1996, 131, 1273-1278.
67. Zuluaga, M. F.; Lange, N. Combination of photodynamic therapy with anti-cancer agents. Curr. Med. Chem. 2008, 15, 1655-1673.
68. Kato, H.; Kawate, N.; Kinoshita, K.; Yamamoto, H.; Furukawa, K.; Hayata, Y. Photodynamic therapy of early-stage lung cancer. Ciba Found. Symp. 1989, 146, 183-194.
69. Lee, J. E.; Park, H. S.; Jung, S. S.; Kim, S. Y.; Kim, J. O. A case of small cell lung cancer treated with chemoradiotherapy followed by photodynamic therapy. Thorax. 2009, 64, 637-639.
70. Endo, C.; Miyamoto, A.; Sakurada, A.; Aikawa, H.; Sagawa, M.; Sato, M.; Saito, Y.; Kondo, T. Results of long-term follow-up of photodynamic therapy for roentgenographically occult bronchogenic squamous cell carcinoma. Chest 2009, 136, 369-375.
71. Watanabe, Y.; Lee, S. W.; Detmar, M.; Ajioka, I.; Dvorak, H. F. Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) delays and induces escape from senescence in human dermal microvascular endothelial cells. Oncogene 1997, 14, 2025-2032.
72. Amirkhosravi, A.; Meyer, T.; Warnes, G.; Amaya, M.; Malik, Z.; Biggerstaff, J. P.; Siddiqui, F. A.; Sherman, P.; Francis, J. L. Pentoxifylline inhibits hypoxia-induced upregulation of tumor cell tissue factor and vascular endothelial growth factor. Thromb. Haemost. 1998, 80, 598-602.
73. Decaussin, M.; Sartelet, H.; Robert, C.; Moro, D.; Claraz, C.; Brambilla, C.; Brambilla, E. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival. J. Pathol. 1999, 188, 369-377.
74. Yano, S.; Shinohara, H.; Herbst, R. S.; Kuniyasu, H.; Bucana, C. D.; Ellis, L. M.; Fidler, I. J. Production of experimental malignant pleural effusions is dependent on invasion of the pleura and expression of vascular endothelial growth factor/vascular permeability factor by human lung cancer cells. Am. J. Pathol. 2000, 157, 1893-1903.
75. Ilhan, N.; Deveci, F. Functional significance of vascular endothelial growth factor and its receptor (receptor-1) in various lung cancer types. Clin. Biochem. 2004, 37, 840-845.
76. Litz, J.; Krystal, G. W. Imatinib inhibits c-Kit-induced hypoxia-inducible factor-1alpha activity and vascular endothelial growth factor expression in small cell lung cancer cells. Mol. Cancer Ther. 2006, 5, 1415-1422.
77. Zhu, Y. M.; Azahri, N. S.; Yu, D. C.; Woll, P. J. Effects of COX-2 inhibition on expression of vascular endothelial growth factor and interleukin-8 in lung cancer cells. BMC Cancer 2008, 8, 218.
78. Carmeliet, P.; Jain, R. K. Angiogenesis in cancer and other diseases. Nature 2000, 407, 249-257.
79. McDonald, D. M.; Choyke, P. L. Imaging of angiogenesis: from microscope to clinic. Nat. Med. 2003, 9, 713-725.
80. Zucker, S.; Mirza, H.; Conner, C. E.; Lorenz, A. F.; Drews, M. H.; Bahou, W. F.; Jesty, J. Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation. Int. J. Cancer 1998, 75, 780-786.
81. Armesilla, A. L.; Lorenzo, E.; Gomez del Arco, P.; Martinez-Martinez, S.; Alfranca, A.; Redondo, J. M. Vascular endothelial growth factor activates nuclear factor of activated T cells in human endothelial cells: a role for tissue factor gene expression. Mol. Cell Biol. 1999, 19, 2032-2043.
82. Akhlynina, T. V.; Jans, D. A.; Rosenkranz, A. A.; Statsyuk, N. V.; Balashova, I. Y.; Toth, G.; Pavo, I.; Rubin, A. B.; Sobolev, A. S. Nuclear targeting of chlorin e6 enhances its photosensitizing activity. J. Biol. Chem. 1997, 272, 20328-20331.